Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer

Yearbook of Urology ◽

10.1016/s0084-4071(08)70108-8 ◽

2007 ◽

Vol 2007 ◽

pp. 137-138

Author(s):

A.S. Kibel

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Α ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.11.026 ◽

2006 ◽

Vol 24 (4) ◽

pp. 344-348 ◽

Author(s):

Fadi N. Joudi ◽

Brian J. Smith ◽

Michael A. O’Donnell

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Α ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.03.010 ◽

2005 ◽

Vol 23 (3) ◽

pp. 218

Author(s):

William A. See

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Alfa ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

INTERIM RESULTS FROM A NATIONAL MULTICENTER PHASE II TRIAL OF COMBINATION BACILLUS CALMETTE-GUERIN PLUS INTERFERON ALFA-2B FOR SUPERFICIAL BLADDER CANCER

The Journal of Urology ◽

10.1097/01.ju.0000136446.37840.0a ◽

2004 ◽

Vol 172 (3) ◽

pp. 888-893 ◽

Author(s):

MICHAEL A. O’DONNELL ◽

KATHLEEN LILLI ◽

CHRISTINA LEOPOLD ◽

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Alfa ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4716 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4716-4716

Author(s):

S. Bazarbashi ◽

M. Raja ◽

S. Kattan ◽

M. Rahal ◽

A. El-Weshi ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Concomitant Administration ◽

Bacillus Calmette Guerin ◽

Preliminary Results ◽

Reduced Dose ◽

Prevention Of Recurrence

Download Full-text

Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4716 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4716-4716

Author(s):

S. Bazarbashi ◽

M. Raja ◽

S. Kattan ◽

M. Rahal ◽

A. El-Weshi ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Concomitant Administration ◽

Bacillus Calmette Guerin ◽

Preliminary Results ◽

Reduced Dose ◽

Prevention Of Recurrence

Download Full-text

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

The Journal of Urology ◽

10.1016/j.juro.2013.03.097 ◽

2013 ◽

Vol 190 (3) ◽

pp. 857-862 ◽

Author(s):

Paolo Gontero ◽

Marco Oderda ◽

Anja Mehnert ◽

Alberto Gurioli ◽

Francesco Marson ◽

...

Keyword(s):

Quality Of Life ◽

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Bacillus Calmette Guerin ◽

Instillation Therapy ◽

Randomized Phase Ii ◽

Nonmuscle Invasive Bladder Cancer

Download Full-text

Commentary on “The impact of intravesical gemcitabine and 1/3 dose bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: Results of a prospective, randomized, phase II trial.” Gontero P, Oderda M, Mehnert A, Gurioli A, Marson F, Lucca I, Rink M, Schmid M, Kluth LA, Pappagallo G, Sogni F, Sanguedolce F, Schiavina R, Martorana G, Shariat SF, Chun F.

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2014.03.021 ◽

2015 ◽

Vol 33 (1) ◽

pp. 46-47

Author(s):

Ashish Kamat

Keyword(s):

Quality Of Life ◽

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Bacillus Calmette Guerin ◽

Instillation Therapy ◽

Randomized Phase Ii ◽

Nonmuscle Invasive Bladder Cancer

Download Full-text

LBA24 CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC): 12 MONTH INTERIM RESULTS FROM A MULTICENTER PHASE II TRIAL

The Journal of Urology ◽

10.1016/j.juro.2018.03.096 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Vignesh T Packiam ◽

Daniel A Barocas ◽

Karim Chamie ◽

Ronald L Davis III ◽

A Karim Kader ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Oncolytic Adenovirus ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Multicenter Phase ◽

Muscle Invasive

Download Full-text

Evaluation of an Unconventional Treatment Modality with Mistletoe Lectin to Prevent Recurrence of Superficial Bladder Cancer: A Randomized Phase ii Trial

The Journal of Urology ◽

10.1016/s0022-5347(05)64834-3 ◽

2002 ◽

Vol 168 (1) ◽

pp. 72-75 ◽

Author(s):

Peter J. Goebell ◽

Thomas Otto ◽

Julia Suhr ◽

Herbert Rübben

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Treatment Modality ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Mistletoe Lectin ◽

Randomized Phase Ii

Download Full-text

PNFLBA-13 INTERIM RESULTS FROM A SINGLE-ARM MULTICENTER PHASE II TRIAL OF CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC)

The Journal of Urology ◽

10.1016/j.juro.2017.03.039 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Vignesh T. Packiam ◽

Daniel A. Barocas ◽

Karim Chamie ◽

Ronald L. Davis III ◽

A. Karim Kader ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Oncolytic Adenovirus ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Multicenter Phase ◽

Muscle Invasive

Download Full-text